Comparison of transrectal ultrasonographic and color Doppler features of benign prostatic hyperplasia and prostate cancer in older men
Introduction: Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are prevalent in elderly men, yet differentiation using two-dimensional transrectal ultrasound (TRUS) remains challenging.
Objective: To compare grayscale TRUS features, color Doppler flow imaging (CDFI), and hemodynamic parameters between BPH and PCa in older men.
Methods: A total of 228 patients (132 BPH, 96 PCa) underwent TRUS from January 2022 to December 2023 at the Department of Urology at the Affiliated Hospital of Yanbian University. Two-dimensional characteristics, CDFI flow distribution, and hemodynamic parameters—including systolic blood flow velocity (Vs), diastolic blood flow velocity (Vd), and resistive index (RI)—were recorded and compared. Receiver operating characteristic (ROC) curves assessed diagnostic performance.
Results: BPH nodules were typically round/oval and located in the transition zone, whereas PCa lesions were predominantly irregular and situated in the peripheral zone. Echogenicity types differed significantly (p = 0.013), with hypoechoic nodules more frequent in PCa (43.8% vs. 3.7%). Pulsed Doppler measurements showed higher Vs, Vd, and RI values in the PCa group than in the BPH group (all p < 0.01). ROC analysis yielded areas under the curves of 0.914, 0.835, and 0.792 for Vs, Vd, and RI, respectively. PCa vessels were thicker, more tortuous, and branched, mainly in the peripheral zone, whereas BPH vessels were thinner and straighter, predominantly in the transition zone.
Conclusion: TRUS with CDFI and hemodynamic assessment may provide useful supplementary information for differentiating BPH from PCa. However, histopathological confirmation via prostate biopsy remains the definitive standard.
- Xiang X, Wang Y. Zhongguo renkou laolinghua xianzhuang, tedian, yuanyin ji duice [Current situation, characteristics, causes and countermeasures of population aging in China]. Chin J Gerontol. 2021;41(18):4149-4152. [In Chinese] doi: 10.3969/j.issn.1005-9202.2021.18.072
- He J, Chen WQ, Li N, et al. Zhongguo qianliexian'ai shaicha yu zao zhen zao zhi zhinan (2022, Beijing) [China guideline for the screening and early detection of prostate cancer (2022, Beijing)]. Chin J Oncol. 2022;44(1):29-53. [In Chinese] doi: 10.3760/cma.j.cn112152-20211226-00975
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660
- Gandaglia G, Leni R, Bray F, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877-892. doi: 10.1016/j.euo.2021.09.006
- Panzone J, Byler T, Bratslavsky G, Goldberg H. Transrectal ultrasound in prostate cancer: current utilization, integration with mpMRI, HIFU and other emerging applications. Cancer Manag Res. 2022;14:1209-1228. doi: 10.2147/CMAR.S265058
- Park BK. Added values of transrectal ultrasonography to magnetic resonance imaging in characterizing prostate cancer: A narrative review. Precis Future Med. 2023;7(3):131-135. doi: 10.23838/pfm.2023.00107
- Thangarasu M, Jayaprakash SP, Selvaraj N, et al. A prospective study on the efficacy of cognitive targeted transrectal ultrasound prostate biopsy in diagnosing clinically significant prostate cancer. Res Rep Urol. 2021;13:207-213. doi: 10.2147/RRU.S300868
- Postema A, Mischi M, de la Rosette J, Wijkstra H. Multiparametric ultrasound in the detection of prostate cancer: a systematic review. World J Urol. 2015;33(11):1651-1659. doi: 10.1007/s00345-015-1523-6
- Ashi K, Kirkham B, Chauhan A, Schultz SM, Brake BJ, Sehgal CM. Quantitative colour Doppler and greyscale ultrasound for evaluating prostate cancer. Ultrasound. 2021;29(2):106-111. doi: 10.1177/1742271X20952825
- Jafari E, Ahmadzadehfar H, Dadgar H, Assadi M. An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: A pictorial essay. World J Nucl Med. 2020;19(3):260-265. doi: 10.4103/wjnm.WJNM_78_19
- Zhong K, Luo W, Li N, et al. CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3. Int J Oncol. 2024;64(2):20. doi: 10.3892/ijo.2024.5608
- Chen T, Wang F, Chen H, et al. Multiparametric transrectal ultrasound for the diagnosis of peripheral zone prostate cancer and clinically significant prostate cancer: novel scoring systems. BMC Urol. 2022;22(1):64. doi: 10.1186/s12894-022-01013-8
- Yu J, Jin XZ, Tian SR, Sinha A, Jin GM. Jing zhichang chaosheng jiancha qianliexian zengshengzheng de youshi ji qi teyixing canshu de linchuang jiazhi [Advantages of transrectal ultrasonography in the diagnosis of benign prostatic hyperplasia and the clinical value of its specific parameters]. China Mod Doct. 2022;60(1):129-132. [In Chinese] doi: 10.3969/j.issn.1673-9701.2021.01.035
- Yin MJ, Jin XZ, Sinha A, Jin GM. Yanbian diqu liushou laoren liangxing qianliexian zengshengzheng weixian yinsu xiangguanxing yanjiu [Risk factors of benign prostatic hyperplasia in the left-behind elderly in Yanbian area]. China Mod Doct. 2020;58(35):92-95. [In Chinese] doi: 10.3969/j.issn.1673-9701.2020.35.023
- Kuru TH, Fütterer JJ, Schiffmann J, et al. Transrectal Ultrasound (US), Contrast-enhanced US, Real-time Elastography, HistoScanning, Magnetic Resonance Imaging (MRI), and MRI-US Fusion Biopsy in the Diagnosis of Prostate Cancer. Eur Urol Focus. 2015;1(2):117-126. doi: 10.1016/j.euf.2015.06.003
- Salloum O, Serboiu C, Taciuc IA, et al. Current Approach to Complications and Difficulties during Transrectal Ultrasound-Guided Prostate Biopsies. J Clin Med. 2024;13(2):487. doi: 10.3390/jcm13020487
- Gao Y, Liao XH, Lu L, et al. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer. Clin Radiol. 2016;71(3):258-264. doi: 10.1016/j.crad.2015.11.013
- Fu S, Tang Y, Tan S, Zhao Y, Cui L. Diagnostic value of transrectal shear wave elastography for prostate cancer detection in peripheral zone: comparison with magnetic resonance imaging. J Endourol. 2020;34(5):558-566. doi: 10.1089/end.2019.0902
- Osorio C, Costa WS, Gallo C, Sampaio F. Expression of stromal elements of prostatic adenocarcinoma in different Gleason scores. Acta Cir Bras. 2019;34(10):e201901005. doi: 10.1590/s0102-865020190100000005
- Schmid HP, Hechelhammer L, Müllhaupt G. Re: Early Results of Unilateral Prostatic Artery Embolization as a Focal Therapy in Patients with Prostate Cancer Under Active Surveillance: Cancer Prostate Embolisation, a Pilot Study. Eur Urol. 2022;81(1):121-122. doi: 10.1016/j.eururo.2021.10.027
- Xu ZW, Zhou CG, Tian W, Shi HB, Liu S. Angiographic findings relevant to prostatic artery embolization in patients with prostate cancer. J Vasc Interv Radiol. 2020;31(6):899-902.e1. doi: 10.1016/j.jvir.2020.02.012
- Zeng S, Wu SQ, Chen C, et al. Performance characteristics of 3-D power Doppler ultrasound (3-D-PD) with the virtual organ computer-aided analysis (VOCAL) technique in the detection of prostate cancer. Ultrasound Med Biol. 2022;48(1):91-97. doi: 10.1016/j.ultrasmedbio.2021.09.016
- Sun Y, Fang J, Shi Y, et al. Machine learning based on radiomics features combining B-mode transrectal ultrasound and contrast-enhanced ultrasound to improve peripheral zone prostate cancer detection. Abdom Radiol (NY). 2023;49(1):141-150. doi: 10.1007/s00261-023-04050-5
- Nong W, Huang Q, Gao Y. Development and validation of a nomogram for predicting prostate cancer based on combining contrast-enhanced transrectal ultrasound and biparametric MRI imaging. Front Oncol. 2023;13:1275773. doi: 10.3389/fonc.2023.1275773
- Ma ZX, Zhao YP, Nie F. Chaosheng zaoying dingliang guanzhu fenxi zai qianliexian liang-exing bingbian zhong de jiazhi [Value of the quantitative perfusion analysis of contrast-enhanced ultrasound in benign and malignant prostate diseases]. J Lanzhou Univ (Med Sci). 2023;49(11):67-71. [In Chinese] doi: 10.13885/j.issn.1000-2812.2023.11.010
- Keskin ET, Kaplanoglu V, Senocak C, Basar H, Bozkurt OF. Transrectal shear wave elastography for detection of prostate cancer. Urologia. 2023;90(2):230-235. doi: 10.1177/03915603231167650
- Tyloch DY, Tyloch JF, Adamowicz J, et al. Comparison of strain and shear wave elastography in prostate cancer detection. Ultrasound Med Biol. 2023;49(3):889-900. doi: 10.1016/j.ultrasmedbio.2022.11.015
- Jeon SS, Kim CK, Park SY, et al. The utility of two-dimensional shear wave elastography for predicting prostate cancer: a preliminary study. Ultrasonography. 2023;42(3):400-409. doi: 10.14366/usg.22202
- Avolio PP, Lughezzani G, Anidjar M, et al. The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review. World J Urol. 2023;41(11):3267-3276. doi: 10.1007/s00345-023-04521-w
- Maffei D, Fasulo V, Avolio PP, et al. Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer. Prostate. 2023;83(9):886-895. doi: 10.1002/pros.24532
- Dias AB, Ghai S. Prostate Cancer Diagnosis with Micro-ultrasound: What We Know now and New Horizons. Radiol Clin North Am. 2024;62(1):189-197. doi: 10.1016/j.rcl.2023.06.014
- Okedere TA, Asaleye CM, Ayoola OO, et al. Correlation of Doppler ultrasound resistive index in the prostatic gland with severity of male lower urinary tract symptoms, prostate volume, and concomitant diabetes mellitus. Cent Eur J Urol. 2023;76(3):199-206. doi: 10.5173/ceju.2023.47
- Onigbinde SO, Asaleye CM, Salako AA, Idowu BM, Onigbinde AO, Laoye A. The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement. Prostate Int. 2023;11(1):46-50. doi: 10.1016/j.prnil.2022.09.001
- Guo YW, Su KB, Lu MH, Liu XP. Incorporation of trans-rectal color Doppler flow imaging and risk-stratification nomogram reduce unnecessary prostate biopsies in suspected prostate cancer patients: a bi-centered retrospective validation study. BMC Urol. 2023;23(1):81. doi: 10.1186/s12894-023-01245-2
- Li H, Yu WL, Wu ML. Jing zhichang jianqiebo tanxingchengxiang dui cunzai xia niaolu zhengzhuang de qianliexian bingbian liang-exing de jianbie zhenduan jiazhi ji qi yingxiang yinsu fenxi [Value of transrectal shear-wave elastography in differential diagnosis of benign and malignant prostate lesions with lower urinary tract symptoms and factors related to severity of such symptoms]. Chin J Med Ultrasound (Electronic Edition). 2023;20(11):1193-1198. [In Chinese] doi: 10.3877/cma.j.issn.2096-1537.2023.11.014
- Pepe P, Pepe L, Fiorentino V, Curduman M, Fraggetta F. Multiparametric MRI targeted prostate biopsy: When omit systematic biopsy? Arch Ital Urol Androl. 2024;96(4):12992. doi: 10.4081/aiua.2024.12992
- Xu G, Li JH, Xiang LH, et al. Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy. Asian J Androl. 2023;25(3):410-415. doi: 10.4103/aja202276
- Agrotis G, Tsougos I, Oikonomou A, et al. Combination of fusion guided multiparametric MRI-transrectal US with systematic biopsy of the prostate for the detection of clinically significant prostate cancer: A prospective single-center study. J Clin Ultrasound. 2023;51(6):1101-1111. doi: 10.1002/jcu.23497
- Zhang ML, Liu YZ, Yao JC, et al. Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer. Front Endocrinol (Lausanne). 2023;14:1137322. doi: 10.3389/fendo.2023.1137322
- Klotz L, Chin J, Black PC, et al. Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial. JAMA Oncol. 2021;7(4):534-542. doi: 10.1001/jamaoncol.2020.7589
- Matuszczak M, Schalken JA, Salagierski M. Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis. Cancers. 2021;13(13):3373. doi: 10.3390/cancers13133373
- Jawli A, Nabi G, Huang ZH. The performance of different parametric ultrasounds in prostate cancer diagnosis: correlation with radical prostatectomy specimens. Cancers. 2024;16(8):1502. doi: 10.3390/cancers16081502
